TriangleNCT00400686 · OUTCOME
Change From Baseline in Hemoglobin at Day 28
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- MEDIAN
- Unit
- g/dL
- Interval / dispersion
- Full Range
- Time frame
- Baseline to Day 28
What was measured
Change from baseline in hemoglobin after treatment with high-dose Epoetin Alfa.
Groups in this outcome
Epoetin Alfa - 80,000 U sc
Epoetin Alfa will be administered 80,000 units subcutaneously every week beginning on Day 1. On Day 28, the dose was adjusted based upon patients' Hemoglobin Levels epoetin alfa: Epoetin alfa will be administered 80,000 u sc every week commencing on study day 1.
| Group | Source count |
|---|---|
| Epoetin Alfa - 80,000 U sc | 31 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Epoetin Alfa - 80,000 U sc | 1.3 | Not reported | -3.0 | 4.4 | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- lower Limit
- -3.0
- upper Limit
- 4.4
- value
- 1.3
- denoms
- counts
- group Id
- OG000
- value
- 31
- units
- Participants
- description
- Change from baseline in hemoglobin after treatment with high-dose Epoetin Alfa.
- dispersion Type
- Full Range
- groups
- description
- Epoetin Alfa will be administered 80,000 units subcutaneously every week beginning on Day 1. On Day 28, the dose was adjusted based upon patients' Hemoglobin Levels epoetin alfa: Epoetin alfa will be administered 80,000 u sc every week commencing on study day 1.
- id
- OG000
- title
- Epoetin Alfa - 80,000 U sc
- param Type
- MEDIAN
- reporting Status
- POSTED
- time Frame
- Baseline to Day 28
- title
- Change From Baseline in Hemoglobin at Day 28
- type
- PRIMARY
- unit Of Measure
- g/dL
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice